VIIBRYD (Cardinal Health)


Welcome to the PulseAid listing for the VIIBRYD drug offered from Cardinal Health. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cardinal Health
NON-PROPRIETARY NAME: vilazodone hydrochloride
SUBSTANCE NAME: VILAZODONE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-04-29
END MARKETING DATE: 0000-00-00


VIIBRYD HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVIIBRYD from Cardinal Health
LABELER NAME: Cardinal Health
DEA SCHEDULE:
ACTIVE STRENGTH: 40(mg/1)
START MARKETING DATE: 2011-04-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55154-4624_e6da11db-7c1e-4086-a659-5359a3ca018a
PRODUCT NDC: 55154-4624
APPLICATION NUMBER: NDA022567

Other VILAZODONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan, Inc.VIIBRYD
Avera McKennan HospitalVIIBRYD
Cardinal HealthVIIBRYD